Interní Med. 2012; 14(8-9): 298-303

Stable angina pectoris: new trends in the treatment

doc.MUDr.Eliška Sovová, Ph.D., MBA
I. interní klinika &ndash, kardiologická, LF UP a FN Olomouc
Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace, LF UP a FN Olomouc

Cardiovascular diseases are an important cause of morbidity and mortality in European countries and in the USA. In this review we discuss

the importance of the management of symptomatic stable angina pectoris. The main therapeutic target is improvement of prognosis

and quality of live with subsequent reduction of symptoms and improvement of exercise capacity. The treatment of stable angina has

improved as a result of be tter understanding of pathogenic mechanisms, the implementation of life style changes, aggressive management

of risk factors, better pharmacological and revascularization therapy.

Keywords: s table angina, therapy

Published: September 20, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sovová E. Stable angina pectoris: new trends in the treatment. Interní Med. 2012;14(8-9):298-303.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zdravotnická ročenka 2010 dostupná na www.uzis.cz.
    2. Hradec J, Bultas J, Želízko M. Stabilní angína pectoris. Doporučený léčebný a diagnostický postup České kardiologické společnosti. Dostupné na www.kardio-cz.cz.
    3. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 2006; 27: 1341-1381. Go to original source... Go to PubMed...
    4. Arrebola-Moreno A, Dungu J, Kaski JC. Treatment strategies for chronic stable angina. Expert Opin Pharmacother 2011 Dec; 12(18): 2833-2844. Go to original source... Go to PubMed...
    5. Vokó Z, de Brouwer S, Lubsen J, Danchin N, Otterstad JE, Dunselman PH, Kirwan BA. Long-term impact of secondary preventive treatments in patients with stable angina. Eur J Epidemiol 2011; 26(5): 375-83. doi: 10.1007/s10654-011-9558-5. Epub 2011 Feb 19. Go to original source... Go to PubMed...
    6. 2007 Guidelines fot the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2007; 25(6): 1105-1187. Go to PubMed...
    7. Widimský J, Cífková R, Špinar J, et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze. Cor Vasa 2008; 50(1): K5-K22.
    8. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005; 19: 801-807. Go to original source... Go to PubMed...
    9. Sovová E, Hrčková I, Kmoníčková A, Marečková J. Hypertenze pro praxi: pro lékaře, pro studenty, pro sestry, pro pacienty. Nakladatelství UP v Olomouci 2008.
    10. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009; 15(6): 540-559. Go to original source... Go to PubMed...
    11. Vaverková H, Soška V, Rosolová H, et al. Doporučení pro diagnostiku a léčbu dyslipidémií v dospělosti. Cor Vasa 2007; 49(3): K73-K86.
    12. Králíková E, Býma S, Cífková E, et al. Doporučení pro léčbu závislosti na tabáku. Supplementum Cor Vasa 2005; 47(9): 71-76.
    13. Piepoli MF, Corra U, Benzer W et al. Secondary prevention through cardiac rehabilitation: physical aktivity counselling and exercise training. Eur Heart J 2010; 31: 1967-1974. Go to original source... Go to PubMed...
    14. Soga Y, Yokoi H, Amemiya K, et al. Safety and efficacy of exercise training after coronary stenting in patients with stable coronary artery disease. Circ J 2011; 75(10): 2379-2386. Epub 2011 Jul 28. Go to original source... Go to PubMed...
    15. Mitka M. Where the elite meet to eat. JAMA 2000; 284: 817-818. Go to original source... Go to PubMed...
    16. Singh RB, Dubnov G, Niaz MA, et al. Effect of an IndoMediterranean diet on progression of coronary artery disease in high-risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet 2002; 360: 1455-1461. Go to original source... Go to PubMed...
    17. http://www.oldwayspt.org/
    18. http://www.choosemyplate.gov/
    19. Aldcroft SA, Taylor NF, Blackstock FC, et al. Psychoeducational rehabilitation for health behavior change in coronary artery disease: a systematic review of controlled trials. J Cardiopulm Rehabil Prev 2011; 31(5): 273-281. Go to original source... Go to PubMed...
    20. Parker JD, Parker JO. Stable angina pectoris: the medical management of symptomatic myocardial ischemia. Can J Cardiol 2012; 28(2 Suppl): S70-80. Go to original source... Go to PubMed...
    21. Fox K, Ford I, Steg PG, et al. Ivabradine for patiens with stable coronary artery disease and left ventricular dysfunction (BEAUTIFUL): a randomised, double blind, placebo-controlled trial. Lancet 2008; 372: 807-816. Go to original source... Go to PubMed...
    22. Danchin N, Marzilli M, Parkhomenko A, et al. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis. Cardiology 2011; 120 (2): 59-72. Epub 2011 Nov 25. Go to original source... Go to PubMed...
    23. Hu B, Li W, Xu T, et al. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials. Clin Cardiol 2011; 34 (6): 395-400. doi: 10.1002/clc.20888. Epub 2011 Apr 27. Go to original source... Go to PubMed...
    24. Truffa AAM, Newby LK, Melloni C. Extended-release ranolazine: critical evaluation of its use in stable angina. Vascular Health and Risk Management 2011; 7: 535-539. Go to original source... Go to PubMed...
    25. http://www.sukl.cz/download/spc/SPC24645.pdf
    26. Gayet JL, Paganelli F, Cohen-Solal A. Update on the medical treatment of stable angina. Arch Cardiovasc Dis 2011; 104(10): 536-544. doi: 10.1016/j.acvd.2011.08.001. Epub 2011 Oct 12. Go to original source...
    27. Izumiya Y, Kojima S, Kojima S, et al. Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris. Atherosclerosis 2011; 214(2): 415-421. Epub 2010 Nov 30. Go to original source... Go to PubMed...
    28. Hulley S, Furberg C, Barrett-Connor E, et al. for the HERS Research Group. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/progestin Replacement Study follow-up (HERS II) J Am Med Assoc 2002; 288: 58-66. Go to original source... Go to PubMed...
    29. Bhupathiraju S, Tucker KL. Coronary heart disease prevention: Nutrients, foods, and dietary patterns. Clinica Chimica Acta 2011; 412: 1493-1514. Go to original source... Go to PubMed...
    30. Tran TL. Antioxidancia a kardiovaskulární onemocnění.. Medicína po promoci 2001; 3: 49-52.
    31. Fitzgerald AG. Coxibs and cardiovascular disease. N Engl Med 2004; 351: 1709-1711. Go to original source... Go to PubMed...
    32. Magro M, Garg S, Serruys PW. Revascularization treatment of stable coronary artery disease. Expert Opin Pharmacother 2011; 12(2): 195-212. Go to original source... Go to PubMed...
    33. Dagenais GR, Lu J, Faxon DP, et al. Effects of optimal medici treatment with or without coronary revascularization on angina and subsequent revascularizations in patiens with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 2011; 123: 1492-1500. Go to original source... Go to PubMed...
    34. Zhang Z, Kolm P, Boden WE, et al. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patiens with stable angina. Circ Cardiovasc Qual Outcomes 2011; 4: 172-182. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.